about
A phase 1/2 study of an adjuvanted varicella-zoster virus subunit vaccine in autologous hematopoietic cell transplant recipients.Double-blind, randomized study of the efficacy and safety of oral pharmacokinetically enhanced amoxicillin-clavulanate (2,000/125 milligrams) versus those of amoxicillin-clavulanate (875/125 milligrams), both given twice daily for 7 days, in treatmeInvestigation of vaccinia virus DNA replication employing a conditional lethal mutant defective in DNA.Efficacy of a new pharmacokinetically enhanced formulation of amoxicillin/clavulanate (2000/125 mg) in adults with community-acquired pneumonia caused by Streptococcus pneumoniae, including penicillin-resistant strains.Efficacy/safety of amoxicillin/clavulanate in adults with bacterial rhinosinusitis
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Elchonon M Berkowitz
@ast
Elchonon M Berkowitz
@en
Elchonon M Berkowitz
@es
Elchonon M Berkowitz
@nl
type
label
Elchonon M Berkowitz
@ast
Elchonon M Berkowitz
@en
Elchonon M Berkowitz
@es
Elchonon M Berkowitz
@nl
prefLabel
Elchonon M Berkowitz
@ast
Elchonon M Berkowitz
@en
Elchonon M Berkowitz
@es
Elchonon M Berkowitz
@nl
P106
P108
P1153
7006782190
P31
P496
0000-0003-2953-894X